LXY6090 – a novel manassantin A derivative – limits breast cancer growth through hypoxia-inducible factor-1 inhibition

LXY6090 – a novel manassantin A derivative – limits breast cancer growth through hypoxia-inducible factor-1 inhibition

Fangfang Lai,1 Qian Liu,2 Xiaoyu Liu,3 Ming Ji,1 Ping Xie,3 Xiaoguang Chen1 1Department of Pharmacology, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 2Department of...

Full description

Bibliographic Details
Main Authors: Lai F, Liu Q, Liu X, Ji M, Xie P, Chen X
Format: Article
Language:English
Published: Dove Medical Press 2016-06-01
Series:OncoTargets and Therapy
Subjects:
Hypoxia-inducible factor 1 (HIF-1)
Manassantin A derivative
anti-tumor
breast cancer
LXY6090
Online Access:https://www.dovepress.com/lxy6090-ndashnbspa-novel-manassantin-a-derivativenbspndashnbsplimits-b-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/lxy6090-ndashnbspa-novel-manassantin-a-derivativenbspndashnbsplimits-b-peer-reviewed-article-OTT

Similar Items